Start exploring your own markets for free

🚀 Try for Free

AI Therapeutics

Light Search completed

Invite

Radar Tracking

Subspaces (4)

Drug Discovery Optimization

Biomarker Identification

Genomic Data Analysis

Drug Repurposing

Pending to review

Not sure yet

Interested

Not interested

Download list

Showing 104 results

Company	Fit assessment	Description	Subspaces	Tags	HQ Location	Founding Date	Employees	Total Funding Raised	Last Funding Event	Received on
AQEMIA	Aqemia effectively utilizes machine learning and quantum algorithms to discover new drug candidates, significantly optimizing the drug discovery process.	Developer of a drug discovery platform designed to discover new drugs for specific therapeutic targets. The company's platform combines machine learning and quantum-inspired statistical mechanics algorithms to generate lead-like molecules for a given target, enabling researchers to efficiently and accurately predict the affinity between drug candidates and therapeutic targets.	Drug Discovery Optimization	Light Search	France	2019	11 - 50	$64.10M	Series A, $32.53M, January 30, 2024	Oct 14, 2024
Every Cure	Every Cure effectively leverages machine learning to discover new drug-disease patterns and expand therapeutic options through drug repurposing.	Developer of an artificial intelligence (AI) medical technology designed to understand repurposed treatments. The company uses AI to identify promising drug repurposing opportunities and create a comprehensive drug repurposing database, structuring it as a biomedical knowledge graph, enabling healthcare professionals to treat their patients more optimally.	Drug Repurposing	Light Search	United States	2022	11 - 50	$108.30M	Grant, $60.00M, October 9, 2024	Oct 14, 2024
SilicoGenesis	SilicoGenesis leverages advanced machine learning technologies to discover new patterns and expand therapeutic options, optimizing the drug discovery process effectively.	Operator of a drug discovery company intended to accelerate the development of biologics through in-silico design and optimization. The company's platform offers computational tools for protein structure prediction, interaction analysis, and developability assessment, enabling customers to identify and optimize promising drug candidates faster and with reduced costs compared to traditional lab-based methods.	Drug Discovery Optimization	Light Search	Belgium	2021	1 - 10		NA	Oct 14, 2024
Ro5	Ro5 leverages machine learning to enhance drug discovery, identify patterns, and expand therapeutic options, including drug repurposing efforts for COVID-19.	Developer of healthcare platform designed to revolutionize drug discovery and delivery process. The company's artificial intelligence and machine learning-based platform feature drug identification, curated database, bioactivity tool, visualization and analytics system and clinical trial analytics that help to speed up drug improvement, development, repurposing and clinical trials, enabling clients to reduce discovery time, increase accuracy, boost clinical trial success and lower costs exponentially.	Drug Repurposing	Light Search	United Kingdom	2018	11 - 50		Seed, February 1, 2020	Oct 14, 2024
Keystonemab	Keystonemab leverages machine learning to discover complex patterns and expand therapeutic uses of existing drugs, including drug repurposing strategies.	Developer of scientific analytics platform designed to derive key insights from vast amounts of data to make smart project-related decisions. The company's platform leverages real-time scientific information from millions of scientific, clinical, and patent documents using AI to accelerate, enabling users the translate knowledge from actionable insights of publications.	Drug Repurposing	Light Search	Netherlands	2019	11 - 50		NA	Oct 14, 2024
Synsight	Synsight leverages machine learning and deep learning to discover new patterns and expand therapeutic options, optimizing the drug discovery process.	Developer of a drug discovery platform designed to combine artificial intelligence, molecular modeling and functional content screening. The company's platform specializes in molecular modeling, bioinformatics and structural biology to secure and efficient new molecules, enabling clients to improve and accelerate their research.	Drug Discovery Optimization	Light Search	Évry-Courcouronnes (France)	2013	1 - 10		Acquired by Iktos, July 2024	Oct 14, 2024
Sinopia Biosciences	Sinopia Biosciences effectively leverages machine learning and multi-omics data to discover new patterns and expand therapeutic options, optimizing the drug discovery process.	Developer of a data-driven drug discovery platform designed to identify and advance novel therapeutics. The company's platform integrates high-throughput screening, multi-omics data, artificial intelligence, and network analysis to identify novel targets and mechanisms of disease, enabling researchers to study diseases and potential drugs in greater detail, which can lead to the development of new treatments.	Drug Discovery Optimization	Light Search	San Diego (United States)	2014	1 - 10	$16.61M	Grant, $2.20M, September 12, 2024	Oct 14, 2024
Applied Discoveries	Applied Discoveries effectively leverages machine learning and pattern discovery to develop new therapeutics, optimizing the drug discovery process.	Developer of drug discovery services using natural products and artificial intelligence. Applied Discoveries Inc. offers a proprietary platform to rapidly identify and analyze potential drug candidates, leveraging the unique interactions found in natural products.	Drug Discovery Optimization	Light Search	United States	2022	1 - 10		NA	Oct 14, 2024
SoftMining	SoftMining effectively leverages machine learning and pattern discovery to expand therapeutics, optimizing the drug discovery process with innovative AI technologies.	Operating of a pharmaceutical platform for providing multiple services for computationally aided drug design and data mining. The company's application is used for toxicology and process optimization. AI-powered systems, drug performance, and new molecules and materials for therapeutics, enabling patients to improve the quality of life designing better and safer drugs, and exploiting biomedical data more efficiently.	Drug Discovery Optimization	Light Search	Italy	2019	1 - 10		NA	Oct 14, 2024
Metanovas Biotech	Metanovas effectively leverages machine learning and AI to enhance drug discovery, pattern discovery, and expand therapeutic options.	Provider of an AI-enabled drug and disease discovery platform. The company provides a drug and disease discovery platform empowered by machine learning and AI to discover novel disease targets, screen for potential drugs, repurpose existing drugs for new indication and optimization ADMET property prediction, enabling a more efficient way to generate new insights and discover more effective medicines to decipher disease biology.	Drug Discovery Optimization Biomarker Identification	Light Search	United States	2021	11 - 50	$10.00M	Seed, $10.00M, March 31, 2022	Oct 14, 2024